Why the study?
Do sulfhydryl-containing ACE inhibitors reduce myocardial ischemia/reperfusion injury in experimental models?
Population
Experimental models of coronary occlusion followed by reperfusion (myocardial ischemia/reperfusion injury)
Comparison
Sulfhydryl-containing ACE inhibitors vs Non-sulfhydryl ACE inhibitors or control
Design
Review
Authors
Loading...
May support dual ACE inhibition plus radical scavenging in experimental reperfusion injury; leaves open clinical translation.
Do sulfhydryl-containing ACE inhibitors reduce myocardial ischemia/reperfusion injury in experimental models?
Sulfhydryl-containing ACE inhibitors like captopril may provide dual benefits in myocardial ischemia/reperfusion injury by both inhibiting ACE and scavenging cytotoxic free radicals.
Przyklenk et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: